|
|
|
40
|
7111G
|
CISPA 1MG/ML INJ (INP/AHI) CISPLATIN
|
CISPLATIN
|
CISPA
|
50ML VIAL
|
BQ
|
19.06
|
19.06
|
INJECTION
|
0
|
VIAL
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
7111R
|
CISPLATIN 1MG/ML INJ (DIL/AHI)
|
CISPLATIN
|
CISPLATIN
|
50ML
|
BQ
|
18.02
|
18.02
|
INJECTION
|
0
|
VIAL
|
DIL
|
FRESENIUS KABI
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
7111S
|
CISPLATIN 1MG/ML INJ (FSB) (BQ)
|
CISPLATIN
|
CISPLATIN
|
50ML VIAL
|
BQ
|
15.01
|
15.0051
|
VIAL
|
50
|
VIAL
|
FSB
|
FLAGSHIP BIOTECH
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
7111W
|
CISPLATIN 1MG/ML INJ (KWA) (BQ)
|
CISPLATIN
|
CISPLATIN
|
50ML
|
BQ
|
16.34
|
16.3371
|
VIAL
|
50
|
VIAL
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
71123
|
CISPLATIN 1MG/ML INJ (KWA) (BQ)
|
CISPLATIN
|
CISPLATIN
|
100ML
|
BQ
|
27.59
|
27.591
|
VIAL
|
0
|
VIAL
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
B
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
71124
|
CISPLATIN 1MG/ML INJ (VEN) (BQ)
|
CISPLATIN
|
CISPLATIN
|
100ML
|
BQ
|
29.19
|
29.1948
|
VIAL
|
0
|
VIAL
|
VEN
|
VENUS REMEDIES LIMITED
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|